Clinical Trial Update: Immunochemoradiotherapy in Patients With Pancreatic Cancer [Phase 1]

View source ↗

Summary

This entry notes the completion of a Phase 1 study evaluating immunochemoradiotherapy for locally advanced pancreatic adenocarcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma

Snippet

Sponsor: Providence Health & Services | Conditions: Locally Advanced Pancreatic Adenocarcinoma | Phase 1 | Status: COMPLETED